文献速递腹部MR

定量胰腺MRI:基于病理学的综述

Quantitative pancreatic MRI: a pathology-based review.
PubMed 文献 · Br J Radiol · 2019-06-14

本综述评估了用于胰腺疾病评估的定量MRI技术,包括secretin增强MR胰胆管成像、扩散加权成像、T1、T2*和脂肪分数映射,以及实验性方法如MR弹性成像和动脉自旋标记,并讨论了其在弥漫性胰腺疾病和囊性/实性局灶性胰腺肿块中的应用及实施挑战。

要点

  • 定量MRI技术可提供比常规解剖序列更多的诊断信息,有望提高诊断准确性。
  • secretin增强MRCP、DWI、T1/T2* mapping和脂肪分数映射已用于胰腺疾病评估。
  • MR弹性成像和动脉自旋标记等实验性方法也在胰腺疾病中得到探索。

核心结论

  • 定量MRI技术可增加诊断信息、提高诊断准确性、改善患者分层,并为治疗试验提供稳健的无创结局指标,最终实现个体化患者护理。

研究设计与样本

  • 综述,评估已建立的定量MRI技术(secretin增强MRCP、DWI、T1/T2* mapping、脂肪分数映射)和实验性方法(MR弹性成像、动脉自旋标记)在胰腺疾病中的应用。

局限性

  • 原文探讨了定量MRI技术实施的一些更广泛的挑战。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

MRI plays an important role in the clinical management of pancreatic disorders and interpretation is reliant on qualitative assessment of anatomy. Conventional sequences capturing pancreatic structure can however be adapted to yield quantitative measures which provide more diagnostic information, with a view to increasing diagnostic accuracy, improving patient stratification, providing robust non-invasive outcome measures for therapeutic trials and ultimately personalizing patient care. In this review, we evaluate the use of established techniques such as secretin-enhanced MR cholangiopancreatography, diffusion-weighted imaging, T 1, T 2* and fat fraction mapping, but also more experimental methods such as MR elastography and arterial spin labelling, and their application to the assessment of diffuse pancreatic disease (including chronic, acute and autoimmune pancreatitis/IgG4 disease, metabolic disease and iron deposition disorders) and cystic/solid focal pancreatic masses. Finally, we explore some of the broader challenges to their implementation and future directions in this promising area.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Chouhan MD, Firmin L, Read S, et al. Quantitative pancreatic MRI: a pathology-based review. Br J Radiol. 2019. PMID: 30982337. doi:10.1259/bjr.20180941

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。